Stock 600529 SHANDONG PHARMACEUTICAL GLASS CO.LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shandong Pharmaceutical Glass Co.Ltd

Equities

600529

CNE000001BG9

Non-Paper Containers & Packaging

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
28.51 CNY -0.70% Intraday chart for Shandong Pharmaceutical Glass Co.Ltd -9.95% +11.37%
Apr. 22 Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 16,445 29,838 26,119 18,847 16,989 18,920 - -
Enterprise Value (EV) 1 16,445 28,706 25,234 17,500 15,524 15,823 15,234 14,522
P/E ratio 35.9 x 52.8 x 44.3 x 27.6 x 21.9 x 19 x 16.2 x 14 x
Yield 1.09% 0.6% 0.68% 1.06% 1.56% 1.7% 1.99% 2.3%
Capitalization / Revenue 5.5 x 8.71 x 6.74 x 4.5 x 3.41 x 3.35 x 2.91 x 2.67 x
EV / Revenue 5.5 x 8.38 x 6.51 x 4.18 x 3.12 x 2.8 x 2.35 x 2.05 x
EV / EBITDA 21.8 x 32.1 x 26.9 x 17.4 x 12.5 x 10 x 8.44 x 6.99 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 4.25 x 7.01 x 5.59 x 2.71 x 2.25 x 2.29 x 2.07 x 1.89 x
Nbr of stocks (in thousands) 594,968 594,968 594,968 663,614 663,614 663,614 - -
Reference price 2 27.64 50.15 43.90 28.40 25.60 28.51 28.51 28.51
Announcement Date 4/28/20 4/26/21 4/25/22 4/24/23 4/22/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,992 3,427 3,875 4,187 4,982 5,645 6,493 7,073
EBITDA 1 755.4 895.2 938.9 1,006 1,241 1,576 1,805 2,076
EBIT 1 586.3 677.3 698.3 711.1 916.4 1,167 1,369 1,583
Operating Margin 19.59% 19.76% 18.02% 16.98% 18.39% 20.67% 21.08% 22.38%
Earnings before Tax (EBT) 1 546 653.5 688.7 708.1 910.8 1,161 1,364 1,584
Net income 1 458.7 564.4 591.1 618.3 775.8 994.5 1,169 1,353
Net margin 15.33% 16.47% 15.25% 14.77% 15.57% 17.62% 18% 19.13%
EPS 2 0.7700 0.9500 0.9900 1.030 1.170 1.497 1.761 2.038
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 0.3000 0.3000 0.3000 0.3000 0.4000 0.4840 0.5660 0.6567
Announcement Date 4/28/20 4/26/21 4/25/22 4/24/23 4/22/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - - - 1,012 1,199 1,237 1,186 2,422 1,251 1,308 1,267 1,316 1,426 1,689
EBITDA - - - - - - - - - - - - - -
EBIT - - - - 137.3 198.4 267.2 - 276.2 - - - - -
Operating Margin - - - - 11.45% 16.05% 22.53% - 22.07% - - - - -
Earnings before Tax (EBT) - - - - - - - - - - - - - -
Net income - - - - - - 219 385.5 - - 220.8 - - -
Net margin - - - - - - 18.47% 15.91% - - 17.42% - - -
EPS 2 0.2000 0.2600 0.2800 0.2900 0.2000 0.2500 0.3309 - 0.3500 0.2400 0.3300 0.3600 0.3700 0.3200
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 4/25/22 4/25/22 8/29/22 10/28/22 4/24/23 4/24/23 8/28/23 8/28/23 10/18/23 4/22/24 4/22/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - 1,132 885 1,347 1,465 3,097 3,685 4,398
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 12.4% 14% 13.3% 12.3% 10.7% 12.2% 12.9% 13.6%
ROA (Net income/ Total Assets) 9.37% 10.5% - 8.14% - 9.76% 10.2% 10.3%
Assets 1 4,897 5,396 - 7,597 - 10,192 11,464 13,122
Book Value Per Share 2 6.500 7.150 7.850 10.50 11.40 12.50 13.80 15.10
Cash Flow per Share 2 1.010 0.9500 1.260 0.3800 1.580 1.650 2.000 2.430
Capex 1 586 534 806 700 669 891 742 939
Capex / Sales 19.57% 15.58% 20.79% 16.71% 13.43% 15.78% 11.43% 13.27%
Announcement Date 4/28/20 4/26/21 4/25/22 4/24/23 4/22/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Shandong Pharmaceutical Glass Co.Ltd

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
28.51 CNY
Average target price
34.95 CNY
Spread / Average Target
+22.60%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glass Containers & Packaging

1st Jan change Capi.
SHANDONG PHARMACEUTICAL GLASS CO.LTD Stock Shandong Pharmaceutical Glass Co.Ltd
+11.37% 2.61B
VERALLIA Stock Verallia
+3.90% 4.52B
VIDRALA, S.A. Stock Vidrala, S.A.
+4.69% 3.38B
O-I GLASS, INC. Stock O-I Glass, Inc.
-8.00% 2.35B
ZIGNAGO VETRO S.P.A. Stock Zignago Vetro S.p.A.
-12.06% 1.18B
VETROPACK HOLDING AG Stock Vetropack Holding AG
-18.80% 688M
ANADOLU CAM SANAYII A.S. Stock Anadolu Cam Sanayii A.S.
0.00% 598M
THE NATIONAL COMPANY FOR GLASS INDUSTRIES Stock The National Company for Glass Industries
+6.75% 375M
CHONGQING ZHENGCHUAN PHARMACEUTICAL PACKAGING CO.,LTD Stock ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd
-27.19% 299M
ANHUI DELI HOUSEHOLD GLASS CO., LTD. Stock Anhui Deli Household Glass Co., Ltd.
-36.73% 228M
Glass Containers & Packaging
  1. Stock Market
  2. Equities
  3. 600529 Stock
  4. Financials Shandong Pharmaceutical Glass Co.Ltd